Chemocentryx Stock Net Income
| CCXIDelisted Stock | USD 51.99 0.00 0.00% |
ChemoCentryx fundamentals help investors to digest information that contributes to ChemoCentryx's financial success or failures. It also enables traders to predict the movement of ChemoCentryx Stock. The fundamental analysis module provides a way to measure ChemoCentryx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ChemoCentryx stock.
ChemoCentryx |
ChemoCentryx Company Net Income Analysis
ChemoCentryx's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current ChemoCentryx Net Income | (133.09 M) |
Most of ChemoCentryx's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ChemoCentryx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, ChemoCentryx reported net income of (133.09 Million). This is 139.0% lower than that of the Healthcare sector and 290.0% lower than that of the Biotechnology industry. The net income for all United States stocks is 123.31% higher than that of the company.
ChemoCentryx Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ChemoCentryx's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ChemoCentryx could also be used in its relative valuation, which is a method of valuing ChemoCentryx by comparing valuation metrics of similar companies.ChemoCentryx is currently under evaluation in net income category among related companies.
ChemoCentryx Fundamentals
| Return On Equity | -46.96 | |||
| Return On Asset | -18.55 | |||
| Operating Margin | (353.17) % | |||
| Current Valuation | 3.45 B | |||
| Shares Outstanding | 70.03 M | |||
| Shares Owned By Insiders | 12.01 % | |||
| Shares Owned By Institutions | 84.39 % | |||
| Number Of Shares Shorted | 7.61 M | |||
| Price To Earning | 40.53 X | |||
| Price To Book | 10.04 X | |||
| Price To Sales | 97.66 X | |||
| Revenue | 37.28 M | |||
| Gross Profit | (51.07 M) | |||
| EBITDA | (127.6 M) | |||
| Net Income | (133.09 M) | |||
| Cash And Equivalents | 328.62 M | |||
| Cash Per Share | 4.61 X | |||
| Total Debt | 73.2 M | |||
| Debt To Equity | 0.31 % | |||
| Current Ratio | 4.54 X | |||
| Book Value Per Share | 5.18 X | |||
| Cash Flow From Operations | (53.5 M) | |||
| Short Ratio | 4.89 X | |||
| Earnings Per Share | (0.94) X | |||
| Number Of Employees | 178 | |||
| Beta | 1.23 | |||
| Market Capitalization | 3.64 B | |||
| Total Asset | 78.16 M | |||
| Retained Earnings | (441.3 M) | |||
| Working Capital | 66.54 M | |||
| Current Asset | 72.03 M | |||
| Current Liabilities | 5.49 M | |||
| Z Score | 19.1 |
About ChemoCentryx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ChemoCentryx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ChemoCentryx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ChemoCentryx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with ChemoCentryx
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ChemoCentryx position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChemoCentryx will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to ChemoCentryx could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ChemoCentryx when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ChemoCentryx - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ChemoCentryx to buy it.
The correlation of ChemoCentryx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ChemoCentryx moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ChemoCentryx moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ChemoCentryx can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in ChemoCentryx Stock
If you are still planning to invest in ChemoCentryx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ChemoCentryx's history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |